Keyword: Eli Lilly

Chemistry & Life Sciences

Securing Supply Chains and Strengthening Partnerships 

20.03.2024 -

Interview with Edgardo Hernandez, President Manufacturing, Lilly


Isomorphic Labs to Collaborate with Eli Lilly and Novartis

10.01.2024 -

Isomorphic Labs announced strategic collaborations with leading pharmaceutical companies, Eli Lilly and Company and Novartis. These partnerships have the potential to be...


Lilly Completes $1.4 Billion Acquisition of Point Biopharma

03.01.2024 -

US drug manufacturer Eli Lilly has completed its acquisition of radiopharmaceutical company Point Biopharma for approximately $1.4 billion.


Lilly Invests in New $2.5 Billion Production Site in Germany

17.11.2023 -

Lilly announced today that it plans to invest €2.3 billion ($2.5 billion) in the construction of a new high-tech manufacturing facility in Alzey, Germany. The company...


Eli Lilly to Acquire Radiopharmaceutical Company Point Biopharma for $1.4 Billion

04.10.2023 -

Eli Lilly announced that it is acquiring radiopharmaceutical company Point Biopharma for $12.50 per share in cash, valuing the deal at approximately $1.4 billion. Point...


Lilly to Acquire Obesity Drug Maker Versanis

17.07.2023 -

Major drugmaker Eli Lilly has agreed to acquire Versanis Bio, a privately held obesity drug maker, for up to $1.925 billion. The transaction is subject to customary...


Lilly Boosts Immunology with Dice Buy

22.06.2023 -

Major drugmaker Eli Lilly is to pay up to $2.4 billion to acquire Dice Therapeutics, a US biotech specializing in developing oral medicines to treat chronic autoimmune...

Markets & Companies

Navigating Uncertainty in the Biopharma Market

17.05.2023 -

Biopharma companies are facing funding challenges in 2023 as interest rates rise and investors are becoming more risk adverse. There is hope on the horizon, say some...